{"id":"https://openalex.org/W2890695404","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e21123","title":"Assessing the uncertainty around the survival estimates used in multi-criteria decision anlaysis (MCDA). the alectinib case in Argentina using the Latin America federation of pharmaceutical industry (FIFARMA) framework.","display_name":"Assessing the uncertainty around the survival estimates used in multi-criteria decision anlaysis (MCDA). the alectinib case in Argentina using the Latin America federation of pharmaceutical industry (FIFARMA) framework.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2890695404","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e21123","mag":"2890695404"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.e21123","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e21123","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e21123","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Panos Orfanos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Panos Orfanos","raw_affiliation_strings":["F-Hoffmann-La Roche Ltd, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F-Hoffmann-La Roche Ltd, Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048183782","display_name":"Claudio Marcelo Martin","orcid":"https://orcid.org/0000-0003-4135-7332","observed_orcids":["https://orcid.org/0000-0003-4135-7332"]},"institutions":[{"id":"https://openalex.org/I4210125926","display_name":"Instituto Alexander Fleming","ror":"https://ror.org/02b0zvv74","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210125926"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Claudio Martin","raw_affiliation_strings":["Instituto Alexander Fleming, Buenos Aires, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Alexander Fleming, Buenos Aires, Argentina;","institution_ids":["https://openalex.org/I4210125926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057644490","display_name":"Mar\u00eda De San Mart\u00edn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mar\u00eda De San Mart\u00edn","raw_affiliation_strings":["NGO Donde Quiero Estar, Buenos Aires, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NGO Donde Quiero Estar, Buenos Aires, Argentina;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049634242","display_name":"Juan Pablo Denamiel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Pablo Denamiel","raw_affiliation_strings":["IOMA, Buenos Aires, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IOMA, Buenos Aires, Argentina;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004351007","display_name":"Francisco E. Tellechea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francisco Tellechea","raw_affiliation_strings":["Roche Argentina, Buenos Aires, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Argentina, Buenos Aires, Argentina;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014194972","display_name":"L. Najun Dubos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Lucas Najun Dubos","raw_affiliation_strings":["Roche Latin America, Buenos Aires, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Latin America, Buenos Aires, Argentina;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112247560","display_name":"Joice Valentim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Joice Valentim","raw_affiliation_strings":["F-Hoffman-La Roche Ltd, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F-Hoffman-La Roche Ltd, Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"e21123","last_page":"e21123"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12443","display_name":"Delphi Technique in Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3312","display_name":"Sociology and Political Science"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alectinib","display_name":"alectinib","score":0.9200000166893005},{"id":"https://openalex.org/keywords/multi-criteria-decision-making","display_name":"multi-criteria decision making","score":0.8659999966621399},{"id":"https://openalex.org/keywords/uncertainty-quantification","display_name":"uncertainty quantification","score":0.6420000195503235},{"id":"https://openalex.org/keywords/survival-estimates","display_name":"survival estimates","score":0.8399999737739563},{"id":"https://openalex.org/keywords/alk-positive-non-small-cell-lung-cancer","display_name":"ALK-positive non-small cell lung cancer","score":0.8529999852180481},{"id":"https://openalex.org/keywords/ceritinib","display_name":"ceritinib","score":0.8050000071525574},{"id":"https://openalex.org/keywords/indirect-comparison","display_name":"indirect comparison","score":0.3630000054836273},{"id":"https://openalex.org/keywords/preference-uncertainty","display_name":"preference uncertainty","score":0.5239999890327454},{"id":"https://openalex.org/keywords/probabilistic-sensitivity-analysis","display_name":"probabilistic sensitivity analysis","score":0.746999979019165},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.3540000021457672},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.44600000977516174},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9750000238418579}],"concepts":[{"id":"https://openalex.org/C2779220645","wikidata":"https://www.wikidata.org/wiki/Q21099132","display_name":"Alectinib","level":5,"score":0.8535979986190796},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7909915447235107},{"id":"https://openalex.org/C11105738","wikidata":"https://www.wikidata.org/wiki/Q1895805","display_name":"Multiple-criteria decision analysis","level":2,"score":0.7309233546257019},{"id":"https://openalex.org/C2779750558","wikidata":"https://www.wikidata.org/wiki/Q21011233","display_name":"Ceritinib","level":5,"score":0.5430887937545776},{"id":"https://openalex.org/C183115368","wikidata":"https://www.wikidata.org/wiki/Q856577","display_name":"Weighting","level":2,"score":0.5119456052780151},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46953046321868896},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3455679714679718},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.340310275554657},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.2529175877571106},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.17134320735931396},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.09980776906013489},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.09860894083976746},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.09495770931243896},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.e21123","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e21123","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e21123","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990376892","https://openalex.org/W2478084061","https://openalex.org/W2542619175","https://openalex.org/W4399707014","https://openalex.org/W2896603794","https://openalex.org/W2074792616","https://openalex.org/W2952614821","https://openalex.org/W4404967634","https://openalex.org/W850633299","https://openalex.org/W2766220592"],"abstract_inverted_index":{"e21123":[0],"Background:":[1],"PFS":[2],"&":[3,88],"OS":[4],"are":[5,272],"key":[6,241],"endpoints":[7],"in":[8,60,69,128],"the":[9,40,43,55,125,132,138,144,147,240,244,281,285,295],"assessment":[10,293],"of":[11,42,49,57,91,111,118,134,190,219,250,294],"cancer":[12],"medicines.":[13],"Existing":[14],"MCDA":[15,65,149,209],"frameworks":[16,258],"focus":[17],"on":[18,30,77,93,124,146,280],"criteria":[19,156],"selection,":[20],"weighting":[21],"and":[22,37,75,104,116,155,172,182,198,221,225,261,274,284],"scoring":[23,154],"techniques":[24],"but":[25,141],"limited":[26,266],"attention":[27],"is":[28,34,52,278],"paid":[29],"how":[31],"actual":[32],"survival":[33,126,260,282],"estimated,":[35],"extrapolated":[36,164],"synthesized":[38],"or":[39,268],"impact":[41,56],"uncertainty":[44,136,145,286],"around":[45,287],"those":[46],"estimates.":[47],"Objective":[48],"this":[50,135],"analysis":[51,121,188],"to":[53,130,247],"assess":[54,259],"these":[58],"elements":[59,150],"MCDA.":[61],"Methods:":[62],"The":[63,208],"FIFARMA":[64],"framework":[66],"was":[67,122,193,232],"applied":[68],"Argentina,":[70],"comparing":[71],"alectinib":[72],"versus":[73,223],"ceritinib":[74,224],"chemotherapy,":[76],"ALK+":[78],"NSCLC,":[79],"previously":[80],"treated":[81],"with":[82,167,175,215],"crizotinib.":[83],"Criterias":[84],"were:":[85],"Efficacy":[86],"(OS":[87],"PFS,":[89],"%":[90],"response":[92],"brain":[94],"metastasis),":[95],"Safety":[96],"(Grade":[97],"3-5":[98],"Adverse":[99],"Ev),":[100],"Economic":[101],"(Treatment":[102],"cost":[103,105],"savings),":[106],"Disease":[107],"burden":[108],"(severity,":[109],"#":[110],"population":[112],"affected,":[113],"unmet":[114],"need)":[115],"Quality":[117],"Evidence.":[119],"Sensitivity":[120],"performed":[123],"estimates":[127,166,200,238],"order":[129],"define":[131],"magnitude":[133],"over":[137],"final":[139],"results":[140],"also":[142],"vs":[143],"other":[148],"such":[151],"as":[152],"weighting,":[153],"selection.":[157],"Survival":[158,237],"sensitivity":[159,187],"scenarios":[160,254],"covered":[161],"median":[162],"survival,":[163],"mean":[165],"different":[168],"parametric":[169],"models,":[170],"H2H":[171],"indirect":[173],"comparisons":[174],"competitive":[176],"treatments.":[177],"To":[178],"address":[179],"both":[180,196],"clinical":[181,197],"preference":[183,199],"uncertainty,":[184],"a":[185,248,290],"probabilistic":[186],"(PSA)":[189],"5,000":[191],"iterations":[192],"performed,":[194],"where":[195],"varied":[201],"simultaneously":[202],"within":[203],"defined":[204],"confidence":[205],"intervals.":[206],"Results:":[207],"baseline":[210],"scores":[211,246],"demonstrated":[212],"alectinib\u2019s":[213],"superiority":[214],"an":[216],"incremental":[217,245],"score":[218],"0.19":[220],"0.34":[222],"chemotherapy":[226],"respectively.":[227],"Limited":[228],"deviation":[229],"(+/-":[230],"7%)":[231],"observed":[233],"between":[234],"participants\u2019":[235],"preferences.":[236],"were":[239],"driver,":[242],"varying":[243],"range":[249],"+/-":[251],"25%":[252],"among":[253],"tested.":[255],"Conclusions:":[256],"Most":[257],"its":[262],"durability":[263],"using":[264],"either":[265],"data":[267],"calculation":[269],"methods":[270],"that":[271],"subjective":[273],"cognitively":[275],"complicated.":[276],"Emphasis":[277],"required":[279],"estimation":[283],"it,":[288],"for":[289],"more":[291],"robust":[292],"technologies.":[296]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2018-09-27T00:00:00"}